All stock reports

PANSARI evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-25T14:01:09.501852+00:00

Metrics

latest_annual_period
2026-03-31
revenue
961006000.0
net_income
198899000.0
operating_cash_flow
-90083000.0
free_cash_flow
-160680000.0
total_assets
4842751000.0
total_liabilities
3300888000.0
total_equity
1541864000.0
cash
29641000.0
total_debt
1002869000.0
revenue_growth
1.4041377930102819
earnings_growth
1.6516684664506927
net_margin
0.20696957146989717
roe
0.12899905568843945
debt_to_equity
0.6504263670466397
cash_conversion
-0.45290825997114115
free_cash_flow_margin
-0.16719978855491016
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-77649ce7ec8715e5f3fc587da49c023d17321e3b7cb44fde2cdbbc0387304ce6
Policy
stock-decisions-v1
Evidence bundle hash
38ccd91139067973663d58e13601ea8b9044c519610ceab63135cfb75001eb01
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: c7739b17cdf3e586036a4a0e44db7d89656ab375693f783dd998550458b1b62f
  • daily-price: fc59b87193fd3bfad446a5586e11f9cf579a852db33acd6f465b162b58d8e0a2
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits